Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance.
Schaison, G
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. [electronic resource] - Haematology and blood transfusion 1987 - 461-5 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
0171-7111
10.1007/978-3-642-71213-5_81 doi
Amsacrine--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Clinical Trials as Topic
Cytarabine--administration & dosage
Drug Administration Schedule
Humans
Leukemia, Lymphoid--drug therapy
Mercaptopurine--administration & dosage
Methotrexate--administration & dosage
Random Allocation
Risk
Vincristine--administration & dosage
Intermediate-risk childhood acute lymphoblastic leukemias: amsacrine + cytosine arabinoside versus intermediate-dose methotrexate for consolidation, and 6-mercaptopurine + methotrexate + vincristine versus monthly pulses for maintenance. [electronic resource] - Haematology and blood transfusion 1987 - 461-5 p. digital
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
0171-7111
10.1007/978-3-642-71213-5_81 doi
Amsacrine--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Child
Clinical Trials as Topic
Cytarabine--administration & dosage
Drug Administration Schedule
Humans
Leukemia, Lymphoid--drug therapy
Mercaptopurine--administration & dosage
Methotrexate--administration & dosage
Random Allocation
Risk
Vincristine--administration & dosage